ArticleScientific reports2026
Body weight variability and mortality in older adults: a nationwide population-based cohort study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although body weight variability has been linked to adverse outcomes, its relationship with mortality in older adults remains unclear. We investigated the association between body weight variability and mortality in older adults using a nationwide cohort from the Korean National Health Insurance Service. Adults aged ≥ 75 years who underwent health checkups between 2012 and 2015 were followed until 2022. Body weight variability was assessed using the variability independent of the mean (VIM) based on at least four measurements. Participants were classified by VIM quartiles and weight-change categories. Mortality risks were estimated using multivariable Cox proportional hazards models. Among 616,696 participants, 195,585 deaths occurred during follow-up. Higher VIM was associated with increased all-cause mortality (adjusted HR for highest vs. lowest quartile, 1.62; 95% CI, 1.60-1.64) in a clear dose-response manner (P for trend < 0.001). This association was consistent across subgroups. High VIM was associated with increased mortality regardless of the direction of weight change. Higher VIM was independently associated with an increased risk of all-cause and cause-specific mortality among older adults. Body weight variability itself, rather than the direction of weight change, may serve as a relevant prognostic marker in this population. Further studies are needed to clarify the clinical implications of body weight variability in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.